Form 4 for INSM INSMED Inc
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001402051-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | INSM | Lewis William | COB, CEO, Dir | A - Grant | — | +21.2K | 325.1K | +7% | — |
| D | 2026-01-06 | 2026-01-02 | INSM | Lewis William | COB, CEO, Dir | A - Grant | $0.00 | +110.4K | 110.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | A | A | 21,172 | — | 325,083 | D | — | — | (F1) Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. (F2) Each RSU was granted on January 2, 2026 for no consideration. |
| 2 | Derivative | Stock Option (right to buy) | 2026-01-02 | A | A | 110,400 | $0.00 | 110,400 | D | $177.12 · — to 2036-01-02 | 110,400 Common Stock | (F3) These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. |